Quick Answer
Vivani Medical, Inc. reported R&D Expense of $18.13 million for fiscal year 2025.
Vivani Medical, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $18.13M | +15.1% |
| 2024 | $15.74M | -7.2% |
| 2023 | $16.97M | +19.8% |
| 2022 | $14.17M | +28.8% |
| 2021 | $11.00M | +127.5% |
| 2020 | $4.84M | -63.2% |
| 2019 | $13.14M | +31.4% |
| 2018 | $10.01M | +26.8% |
| 2017 | $7.89M | +47.6% |
| 2016 | $5.35M | +76.1% |
| 2015 | $3.04M | -39.8% |
| 2014 | $5.04M | +55.2% |
| 2013 | $3.25M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $4.52M | +7.5% | -5.0% |
| June 30, 2025 | $4.76M | +35.5% | +12.9% |
| March 31, 2025 | $4.22M | +13.2% | +0.3% |
| September 30, 2024 | $4.20M | -5.4% | +19.6% |
| June 30, 2024 | $3.51M | -9.1% | -5.7% |
| March 31, 2024 | $3.73M | -5.8% | -16.1% |
| September 30, 2023 | $4.44M | +15.1% | +14.9% |
| June 30, 2023 | $3.86M | +20.6% | -2.3% |
- Vivani Medical, Inc. showed an increase of +15.1% in R&D Expense compared to the prior fiscal year.
- Over the 2013–2025 period, Vivani Medical, Inc.’s r&d expense has grown by 457.9% (from $3.25 million to $18.13 million).
- The most recent figure is from Vivani Medical, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: